Belite Bio (ADR) (BLTE)
Develops oral investigational therapies for retinal and metabolic diseases.
$168.62
vs last close−6.73 (−3.84%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 47 days
EPS estimate
−$0.79
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.32−$0.45−$0.50−$0.65−$0.38−$0.34−$0.70Pending
Estimate−$0.30−$0.36−$0.47−$0.53−$0.56−$0.60−$0.73−$0.79
Surprise−6.7%−25.0%−6.4%−22.6%+32.1%+43.3%+4.1%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————$16.7M———
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.00 | — | — |
| Sep 2028 | $0.00 | — | — |
| Jun 2028 | $0.00 | — | — |
| Mar 2028 | $0.00 | — | — |
| Dec 2027 | $0.53 | — | — |
| Sep 2027 | −$0.32 | — | — |
| Jun 2027 | −$0.90 | — | — |
| Mar 2027 | $1.58 | — | — |
| Dec 2026 | −$0.95 | — | — |
| Nov 2026 | −$0.79 | — | — |
| Aug 2026 | −$0.73 | −$0.70 | +4.1% |
| May 2026 | −$0.60 | −$0.34 | +43.3% |
| Mar 2026 | −$0.56 | −$0.38 | +32.1% |
| Nov 2025 | −$0.53 | −$0.65 | −22.6% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Sep 2022 | |||
| Aug 2022 | |||
| Mar 2022 | |||
| Apr 2022 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.00 | — | — | $101.3M | — | — | — |
| Sep 2028 | $0.00 | — | — | $97.5M | — | — | — |
| Jun 2028 | $0.00 | — | — | $90.0M | — | — | — |
| Mar 2028 | $0.00 | — | — | $86.3M | — | — | — |
| Dec 2027 | $0.53 | — | — | $100.7M | — | — | — |
| Sep 2027 | −$0.32 | — | — | $52.2M | — | — | — |
| Jun 2027 | −$0.90 | — | — | $20.1M | — | — | — |
| Mar 2027 | $1.58 | — | — | $124.2M | — | — | — |
| Dec 2026 | −$0.95 | — | — | $25.7M | — | — | — |
| Nov 9, 2026 | −$0.79 | — | — | $0 | — | — | — |
| Aug 12, 2026 | −$0.73 | −$0.70 | +4.1% | — | — | — | −2.1% |
| May 20, 2026 | −$0.60 | −$0.34 | +43.3% | — | — | — | +0.6% |
| Mar 2, 2026 | −$0.56 | −$0.38 | +32.1% | $16.7M | — | — | −5.5% |
| Nov 10, 2025 | −$0.53 | −$0.65 | −22.6% | — | — | — | −9.9% |
| Aug 11, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 17, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 9, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 11, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 10, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Sep 30, 2022 | |||||||
| Aug 10, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Apr 29, 2022 | |||||||
| Sep 30, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 |